CSL 2.08% $285.10 csl limited

Ann: Top-line Results from the Phase 3 AEGIS-II Trial, page-36

  1. 3,097 Posts.
    lightbulb Created with Sketch. 193
    Bill Mezzanotte warned us at capital markets day that the “top line results would be what they would be” but that it would require further analysis to slice and dice the numbers to find the group with most benefit and that there would likely be a number of follow up communications in the months after top line results.

    listen at the 4hour and 1 minute mark.
 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.